References
Hogancamp WE, Rodriguez M, Weinshenker BG (1997) The epidemiology of multiple sclerosis. Clin Proc 72:871-78
Giordano M, D'Alfonso S, Momigliano-Richiardi P (2002) Genetics of multiple sclerosis: linkage and association studies. Am J Pharmacogenom 2:37-8
Kantarci OH, de Andrade M, Weinshenker BG (2002) Identifying disease modifying genes in multiple sclerosis. J Neuroimmunol 123:144-9
Fernandez O, Fernandez V, Alonso A, Caballero A, Luque G, Bravo M, Leon A, Mayorga C, Leyva L, de Ramon E (2004) DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain. J Neurol 251:440-
Matesanz F, Fedetz M, Leyva L, Delgado C, Fernandez O, Alcina A (2004) Effects of the multiple sclerosis associated -330 promoter polymorphism in IL2 allelic expression. J Neuroimmunol 148:212-17
Akesson E, Coraddu F, Marrosu MG, Massacesi L, Hensiek A, Harbo HF, Oturai A, Trojano M, Momigliano- Richiardi P, Cocco E, Murru R, Hillert J, Compston A, Sawcer S (2003) Refining the linkage analysis on chromosome 10 in 449 sib-pairs with multiple sclerosis. J Neuroimmunol 143:31-8
Sarfarazi M, Child A, Stoilova D, Brice G, Desai T, Trifan OC Poinoosawmy D, Crick RP (1998) Localization of the fourth locus (GLC1E) for adult-onset primary open-angle glaucoma to the 10p15-p14 region. Am J Hum Genet 62:641-52
Reed P, Cucca F, Jenkins S, Merriman M, Wilson A, McKinney P, Bosi E, Joner G, Ronningen K, Thorsby E, Undlien D, Merriman T, Barnett A, Bain S, Todd J (1997) Evidence for a type 1 diabetes susceptibility locus (IDDM10) on human chromosome 10p11-q11. Hum Mol Genet 6:1011-016
Vella A, Cooper JD, Lowe CE, Walker N, Nutland S, Widmer B, Jones R, Ring SM, McArdle W, Pembrey ME, Strachan DP, Dunger DB, Twells RC, Clayton DG, Todd JA (2005) Localization of a Type 1 Diabetes Locus in the IL2RA/CD25 Region by Use of Tag Single-Nucleotide Polymorphisms. Am J Hum Genet 76:773-79
Matesanz F, Fedetz M, Collado-Romero M, Fernandez O, Guerrero M, Delgado C, Alcina A (2001) Allelic expression and interleukin-2 polymorphisms in multiple sclerosis. J Neuroimmunol 119:101-
Malek TR, Bayer AL (2004) Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 4:665-7
Sharfe N, Dadi HK, Shahar M, Roifman CM (1997) Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc Natl Acad Sci U S A 94:3168-171
Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-31
McGeachy MJ, Stephens LA, Anderton SM (2005) Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4 + CD25+ regulatory cells within the central nervous system. J Immunol 175:3025-2
Lucchinetti CF, Bruck W, Lassmann H (2004) Evidence for pathogenic heterogeneity in multiple sclerosis. Ann Neurol 56:308
Kim HP, Kelly J, Leonard WJ (2001) The basis for IL-2-induced IL-2 receptor alpha chain gene regulation: importance of two widely separated IL-2 response elements. Immunity 15:159-72
Yeh JH, Lecine P, Nunes JA, Spicuglia S, Ferrier P, Olive D, Imbert J (2001) Novel CD28-responsive enhancer activated by CREB/ATF and AP-1 families in the human interleukin-2 receptor alpha-chain locus. Mol Cell Biol 21:4515-527
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Matesanz, F., Caro-Maldonado, A., Fedetz, M. et al. IL2RA/CD25 polymorphisms contribute to multiple sclerosis susceptibility. J Neurol 254, 682–684 (2007). https://doi.org/10.1007/s00415-006-0416-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-006-0416-4